chronic lymphocytic leukemia

Biotech

Tough markets take a double hit on Vincerx with layoffs

Cancer-focused Vincerx is laying off staff and cutting its pipeline in an effort to try to stay alive by extending its cash runway into late 2024.
Annalee Armstrong Jun 7, 2022 10:00am

TG's leukemia combo clears phase 3, aims for 2020 filing

May 5, 2020 9:55am

Merck inks $2.7B ArQule deal, teeing up cancer race with Lilly

Dec 9, 2019 10:25am

Lilly plots 'ambitious' cancer program after sharing early data

Dec 8, 2019 4:30pm

TG Therapeutics’ umbralisib shrinks tumors in 52% of MZL patients

Apr 1, 2019 8:30am

TG clears board data review on way to key PFS readout

Mar 8, 2019 10:15am